Mass administrations of antimalarial drugs

Trends in Parasitology

Volumn 19, Issue 10, 2003, Pages 452-460

  Von Seidlein, Lorenz ^a   Greenwood, Brian M ^b  

^a International Vaccine Institute   (South Korea)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

8 AMINOQUINOLINE PLASMOQUINE; AMODIAQUINE; ANTIMALARIAL AGENT; ARTESUNATE; CHLOROQUINE; CHLORPHENOTANE; CHLORPROGUANIL PLUS DAPSONE; PAMAQUINE; PIPERAQUINE; PRIMAQUINE; PROGUANIL; PROPOXUR; PYRIMETHAMINE; SULFADOXINE; UNCLASSIFIED DRUG;

BLOOD DYSCRASIA; CLINICAL TRIAL; DISEASE RESISTANCE; DISEASE TRANSMISSION; DRUG SAFETY; FETUS DISEASE; HEALTH PROGRAM; HEALTH PROMOTION; HEMOLYSIS; HUMAN; MALARIA; MALARIA CONTROL; OUTCOMES RESEARCH; PARASITEMIA; PREVALENCE; REVIEW; SIDE EFFECT; TREATMENT OUTCOME;

ANIMALS; ANTIMALARIALS; DRUG RESISTANCE; GERM CELLS; HUMANS; INSECT CONTROL; MALARIA; SEASONS; TREATMENT OUTCOME;

PROTOZOA;

EID: 0242716181     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2003.08.003     Document Type: Review

References (64)

1. Barber M., et al. Malaria studies on the Firestone rubber plantation in Liberia, West Africa. Am. J. Hyg. 15:1932;601-633.
2. World Health Organization (1951) Technical Report Series No 38 World Health Organization.
3. World Health Organization (1971) Technical Report Series No 467 World Health Organization.
4. Wernsdorfer W.H. The biological and epidemiological basis of drug resistance in malaria parasites. Southeast Asian J. Trop. Med. Public Health. 23:(Suppl. 4):1992;123-129.
5. Verdrager J. Localized permanent epidemics: the genesis of chloroquine resistance in Plasmodium falciparum. Southeast Asian J. Trop. Med. Public Health. 26:1995;23-28.
6. Verdrager J. Epidemiology of the emergence and spread of drug-resistant falciparum malaria in South-East Asia and Australasia. J. Trop. Med. Hyg. 89:1986;277-289.
7. Payne D. Did medicated salt hasten the spread of chloroquine resistance in Plasmodium falciparum? Parasitol. Today. 4:1988;112-115.
8. Strangways-Dixon D. Paludrine (Proguanil) as a malarial prophylactic amongst African labour in Kenya. E. African Med. J. 28:1950;127-130.
9. Matson A.T. The history of malaria in Nandi. E. African Med. J. 34:1957;431-441.
10. Roberts J.M. The control of epidemic malaria in the highlands of Western Kenya. Part II. The campaign. J. Trop. Med. Hyg. 67:1964;191-199.
11. Roberts J.M. The control of epidemic malaria in the highlands of Western Kenya. Part III. After the campaign. J. Trop. Med. Hyg. 59:1964;230-237.
12. De Zulueta J., et al. The results of the first year of a malaria eradication pilot project in northern Kigezi (Uganda). East Afr. Med. J. 38:1961;1-26.
13. De Zulueta J., et al. A malaria eradication experiment in the highlands of Kigezi (Uganda). East Afr. Med. J. 41:1964;102-120.
14. Escudie A., et al. Resultat d'une chimoprophylaxie antipaludique de masse par l'association amino-4-quinoleine/amino-8-quinoleine en milieu rural africain de la region de Bobo-Dioulasso (Haute Volta). Méd. Trop. 22:1962;268-305.
15. Cavalie P., Mouchet J. Les campagnes experimentales d'eradication du paludisme dans le nord de la Republique du Cameroun. II Les operations de lutte antipaludique et leurs resultats. Méd. Trop. 22:1962;95-118.
16. Dola S. Mass drug administration as a supplementary attack measure in malaria eradication programme. East Afr. Med. J. 51:1974;529-531.
17. Najera, J.A. et al. (1973) Mass drug administration and DDT indoor-spraying as antimalarial measures in the Northern savanna of Nigeria, WHO/MAL/73.817 (WHO/MAL/73.817) World Health Organization.
18. Macdonald, G. et al. (1967) The potential value of mass treatment in malaria eradication (WHO/MAL/67.615) WHO.
19. Molineaux L., Gramiccia G. The Garki Project. Research on the Epidemiology and Control of Malaria in the Sudan Savanna of West Africa. 1980;WHO.
20. von Seidlein, L. et al. The effect of mass administration of pyrimethamine/sulfadoxine combined with artesunate on malaria transmission: a double blind, community randomised, placebo controlled trial in The Gambia. Trans. R. Soc. Trop. Med. Hyg. (in press).
21. Garfield R. Changes in malaria incidence after mass drug administration in Nicaragua. Lancet. 2:1983;500-503.
22. Garfield R. Malaria control in Nicaragua: social and political influences on disease transmission and control activities. Lancet. 354:1999;414-418.
23. Lakshmanacharyulu T., et al. Control of malaria in a river valley project. Bull. Indian Soc. Malaria and Other Communicable Dis. 5:1968;94-105.
24. Singh M.V., et al. Epidemiologic study of focal outbreak of malaria in consolidation phase area and evaluation of remedial measures in Uttar Pradesh (India). Bull. Indian Soc. Malaria & Other Communicable Dis. 5:1968;207-220.
25. Sehgal J.K. Progress of malaria eradication in Orissa state during 1965-66. Bull. Indian Soc. Malaria & Other Communicable Dis. 5:1968;88-93.
26. Baukapur S.N. A focal outbreak of malaria in Valsad district, Gujarat State. J. Commun. Dis. 16:1984;268-272.
27. Kondrashin A.V. Mass drug administration in Andhra Pradesh in areas under Plasmodium falciparum containment programme. J. Commun. Dis. 17:1985;293-299.
28. Hii J.L. The influence of permethrin-impregnated bednets and mass drug administration on the incidence of Plasmodium falciparum malaria in children in Sabah, Malaysia. Med. Vet. Entomol. 1:1987;397-407.
29. Doi H. Chemotherapeutic malaria control operation by single dose of Fansidar plus primaquine in North Sumatra, Indonesia. Southeast Asian J. Trop. Med. Public Health. 20:1989;341-349.
30. Kaneko A., et al. Island malaria control in eastern Melanasia: 1) Malaria eliminated from a small island by 9-week mass drug administration and impregnated bednets. Jpn. J. Parasitol. 43:1994;358-370.
31. Kaneko A., et al. Malaria eradication on islands. Lancet. 356:2000;1560-1564.
32. Yip K. Antimalarial work in China: a historical perspective. Parassitologia. 40:1998;29-38.
33. Ministry of Health. The principle and usage of antimalarial drugs in China. Chin. J. Parasit Dis. Con. 15:2002;129-130.
34. Tang L. Progress in malaria control in China. Chin. Med. J. 113:2000;89-92.
35. Yang H., et al. Assay of sensitivity of Plasmodium falciparum to chloroquine, amodiaquine, piperaquine, mefloquine and quinine in Yunnan province. Chin. J. Parasit. Parasitic Dis. 17:1999;143-145.
36. Dequan L., et al. Present status of the sensitivity Plasmodium falciparum to antimalarials in China. Chin. J. Parasit. Parasitic Dis. 14:1996;37-41.
37. Pinotti, M. (1953) Chemoprophylaxis of malaria by the association of an antimalarial drug to the sodium chloride used daily in the preparation of meals. In V Congrés Internationaux de Médicine Tropicale et du Paludisme (Vol. 2), pp. 248-258.
38. Pinotti M. Um novo metodo de profilaxia da malaria: Associacao de uma droga antimalarica ao sal de cozinha usado na alimentacao diaria. Revista Brasileira de Malariologia e Doencas Tropicais. 6:1954;5-12.
39. Meuwissen J.H.E.T. The use of medicated salt in an antimalaria campaign in West New Guinea. Trop. Geogr. Med. 16:1964;245-255.
40. Giglioli G. Interruption of malaria transmission by chloroquinized salt in Guyana, with observations on a chloroquine-resistant strain of Plasmodium falciparum. Bull. WHO. 36:1967;283-301.
41. Verdrager J. Epidemiology of emergence and spread of drug-resistant falciparum malaria in Southeast Asia. Southeast Asian J. Trop. Med. Public Health. 17:1986;111-118.
42. Eyles D.E., et al. Plasmodium falciparum resistant to chloroquine in Cambodia. Am. J. Trop. Med. Hyg. 12:1963;840.
43. WHO (1963) Malaria eradication WHO/MAL/376-AFR/MAL/9/62 (WHO/MAL/376-AFR/MAL/9/62).
44. Hamon J., et al. Bilan de quatorze années de lutte contre le paludisme dans les pays francophones d'Afrique tropicale et a Madagascar. Considérations sur la persistance de la transmission et perspectives d'avenir. Bull. Soc. Pathol. Exot. 56:1963;933-971.
45. Onori E. Experience with mass drug administration as a supplementary attack measure in areas of vivax malaria. Bull. WHO. 47:1972;543-548.
46. Doi H., et al. Chemotherapeutic malaria control operation by single dose of Fansidar plus primaquine in North Sumatra, Indonesia. Southeast Asian J. Trop. Med. Public Health. 20:1989;341-349.
47. Molineaux K., Gramiccia G.G.W.H.O. The Garki Project. Research on the Epidemiology and Control of Malaria in the Sudan Savanna of West Africa. 1980;WHO.
48. Donner A., Klar N. Design and Analysis of Cluster Randomization Trials in Health Research. 2000;Arnold.
49. Ashby M., et al. An annotated bibliography of methods for analysing correlated categorical data. Stat. Med. 11:1992;67-99.
50. Zeger S.L., Liang K.Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 42:1986;121-130.
51. Zeger S.L., Liang K.Y. An overview of methods for the analysis of longitudinal data. Stat. Med. 11:1992;1825-1839.
52. Bennett S., et al. Methods for the analysis of incidence rates in cluster randomized trials. Int. J. Epidemiol. 41:2002;839-846.
53. Bhasin V.K., Nair L. In vitro selection of Plasmodium falciparum lines resistant to dihydrofolate-reductase inhibitors and cross resistance studies. Jpn. J. Med. Sci. Biol. 49:1996;1-14.
54. Deen J., et al. The safety of the combination artesunate and pyrimethamine/sulphadoxine given during pregnancy. Trans. R. Soc. Trop. Med. Hyg. 95:2001;424-428.
55. Shulman C.E., et al. Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial. Lancet. 353:1999;632-636.
56. Schellenberg D., et al. Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial. Lancet. 357:2001;1471-1477.
57. Massaga J.J., et al. Effect of intermittent treatment with amodiaquine on anaemia and malarial fevers in infants in Tanzania: a randomised placebo-controlled trial. Lancet. 361:2003;1853-1860.
58. Expert Advisory Committee on Malaria, Ministry of Health. Malaria situation in the People's Republic of China in 1990. Chin. J. Parasitol. Parasit. Dis. 1991-2001;9-259.
59. Yang L. Progress in malaria control in China. Chin. Med. J. 113:2000;89-92.
60. McCormack C.P., Lwihula G. Failure to participate in a malaria chemosupression program: North Mara, Tanzania. J. Trop. Med. Hyg. 86:1983;99-107.
61. Garfield R.M. Malaria in Nicaragua: an update. Lancet. 1:1984;1125.
62. Jaffar S., et al. Preparation for a pneumococcal vaccine trial in The Gambia: individual or community randomisation? Vaccine. 18:1999;633-640.
63. Smith P.G., Morrow R. Field Trials of Health Interventions in Developing Countries: A Toolbox. 1996;Macmillan.
64. Blum D., Feachem R. Measuring the impact of water supply and sanitation investments on diarrheal diseases: problems of methodology. Int. J. Epidemiol. 12:1983;357-365.